About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Histograft
Betuvax
Nextgen
Gemabank
Genetico
Biotechnology Developments
Genotarget
Reprobank
Vitacel
13.01.2025
Press releases
200 patients with spinal diseases have undergone treatment using gene-activated material
28.12.2024
Press releases
Cifra Broker has published an analytical review of Artgen Biotech for 9 months of 2024
20.12.2024
Press releases
Vaccine against cat allergies attracts venture capital investments
17.12.2024
Press releases
Nextgen Company has become a member of the Chamber of Commerce and Industry of the Russian Federation
13.12.2024
Press releases
Artgen Biotech is in the GR rating of the largest Russian companies without government participation
11.12.2024
Press releases
Tauren Investments has published an analytical report on Gemabank
09.12.2024
Press releases
Gemabank will pay dividends for 9 months of 2024
1
2
3
4
…
17
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
